Family Medicine Doctors in Kirtland Afb, NM Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Dr. Patric Yves Nassaux, M.D. Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 2050a Second Street Se,, Kirtland Afb, NM 87111 Phone: 505-853-1611

Dr. Edgar Rodriguez, M.D., M.P.H. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Andrew Alton, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Dr. Antonio J. Eppolito, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2050 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-853-0140

Jay Ronald Allen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3562

Susan Roberts, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

Dr. Kenneth Egerstrom, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-7695

Dr. David Breckenridge Sproat, MD, MSA, FAAFP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2050a 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-846-3200

James Curtis Bloom, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2050 2nd St Se, Kirtland Afb, NM 87117 Phone: 505-853-0140

News Archive

Salk Institute to establish Helmsley Center for Genomic Medicine

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases, today announced that preliminary top-line results of its Phase 3 clinical trial evaluating the safety and efficacy of its treatment for sickle cell anemia and sickle beta-0 thalassemia met both the primary and secondary endpoints of the clinical trial.

Experts provides guidance to ensure safe, effective physical activity for osteoporosis patients

​Today, experts from the Too Fit to Fracture Initiative presented the results of an international consensus process to establish exercise recommendations for people with osteoporosis, with or without spine fractures.

Akonni Biosystems receives patent for TruTip Extraction Kits

Akonni Biosystems, a developer of low-cost, multiplex molecular diagnostic testing systems, today announced that the United States Patent and Trademark Office issued a patent on July 20, 2010 for its method for rapidly purifying nucleic acids. U.S. Patent No. 7,759,112 entitled, "Apparatus, system, and method for purifying nucleic acids" protects the Company's use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification. The patent is owned by Akonni Biosystems.

Read more Medical News

› Verified 1 days ago